Global Real World Evidence/RWE Solutions Market Size study, By Component (Services, Data Sets, Clinical setting data, Claims data, Pharmacy data, Patient powered data), By Therapeutic area (Oncology, Cardiovascular, Neurology, Immunology, Others), By End Users (Pharmaceutical and Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End Users), and Regional Forecasts 2022-2028Global Real World Evidence/RWE Solutions Market is valued approximately USD 1.03 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2022-2028. Real World Evidence in medicine refers to the evidences that are collected from real world data, which is a factual data acquire from outside controlled trials and produced through routine clinical practice. RWD creates extrapolative results, insights, prudence on diseases, unmet patient needs, medical devices, and the value provided by the goods to patient demographics and sub-populations as per the observational data. RWE offers data about various areas such as effectiveness studies, course of disease & natural history, outcome study, and safety surveillance. The growing support of the governments for the penetration of RWE solutions, the growing prevalence of chronic diseases, the rising geriatric population, coupled with the increasing R&D investments is the primary factors that may augment the market demand across the globe. For instance, in May 2021, Five RWD and analytics organizations that is Aetion, Flatiron Health, IQVIA, Syapse, and Tempus come into an industry association with the objective of advance the usage of RWE solutions to support governmental decisions. Thereby, an increasing number of companies' initiatives for promoting the adoption of the RWE solution are further driving the market growth. However, the lack of universal acceptance for methodological standards and data processing infrastructure impedes the growth of the market over the forecast period of 2022-2028. Also, a growing focus on end-to-end RWE services is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the Global Real World Evidence/RWE Solutions Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to increasing government initiatives for the adoption of RWE studies, coupled with the growing number of RWE service providers. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the presence of many Contract Research Organizations (CROs) and manufacturing companies, as well as growing demand for better healthcare services, would create lucrative growth prospects for the Real World Evidence/RWE Solutions Market across the Asia-Pacific region.
Major market players included in this report are:
Cognizant
Oracle
ICON, plc.
PAREXEL International Corporation
Cerner Corporation
Flatiron Health
PerkinElmer
Anthem
Cegedim Health Data
SAS

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Component
Services
Data Sets
Clinical Setting Data
Claims Data
Pharmacy Data
Patient Powered Data
By Therapeutic area
Oncology
Cardiovascular
Neurology
Immunology
Others
By End Users
Pharmaceutical and Medical Devices Companies
Healthcare Providers
Healthcare Payers
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028

Target Audience of the Global Real World Evidence/RWE Solutions Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Cognizant
Oracle
ICON, plc.
PAREXEL International Corporation
Cerner Corporation
Flatiron Health
PerkinElmer
Anthem
Cegedim Health Data
SAS